A carregar...
Preclinical testing of an Atr inhibitor demonstrates improved response to standard therapies for esophageal cancer
BACKGROUND AND PURPOSE: Esophageal cancer has a persistently low 5-year survival rate and has recently been classified as a cancer of unmet need by Cancer Research UK. Consequently, new approaches to therapy are urgently required. Here, we tested the hypothesis that an ATR inhibitor, VX-970, used in...
Na minha lista:
Publicado no: | Radiother Oncol |
---|---|
Main Authors: | , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Elsevier Scientific Publishers
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5154234/ https://ncbi.nlm.nih.gov/pubmed/27839769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2016.10.023 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|